89bio Inc (ETNB)

8.76 -0.16 (-1.74%) USD  |  NASDAQ  |  Nov 14, 16:00
8.50 -0.26 (-2.97%) After-Hours: 17:21
More

89bio Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for ETNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Madrigal Pharmaceuticals Inc --
Eli Lilly and Co Upgrade
Viking Therapeutics Inc --
Akero Therapeutics Inc --
NovaBay Pharmaceuticals Inc Upgrade